The single-and multiple-dose pharmacokinetics and dose-proportionality of oral dolasetron and its active metabolites over the therapeutic dose range was investigated in 18 healthy men. In an open-label, randomized, complete three-way crossover design, each subject received three separate doses: 50,
โฆ LIBER โฆ
Comparison of the pharmacokinetics of dolasetron and its major active metabolite, reduced dolasetron, in dog
โ Scribed by J. Dow; G. F. Di Francesco; C. Berg
- Book ID
- 109388546
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 116 KB
- Volume
- 85
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Single- and multiple-dose pharmacokineti
โ
Dan C. Dimmitt; Youn Sung Choo; Lorene A. Martin; Thangam Arumugham; William F.
๐
Article
๐
1999
๐
John Wiley and Sons
๐
English
โ 132 KB
๐ 2 views
Effect of lamotrigine on the pharmacokin
โ
K. M. Matar; P. J. Nicholls; S. A. Bawazir; K. I. Al-Khamis; M. I. Al-Hassan
๐
Article
๐
2001
๐
Springer-Verlag
๐
English
โ 563 KB
Actions of dolasetron and its major meta
โ
Robert Dumaine; Hali A. Hartmann; Derek J. Leishman; Arthur M. Brown; Martin Gal
๐
Article
๐
1996
๐
John Wiley and Sons
๐
English
โ 695 KB
The present study evaluated the effects of the anti-emetic 5-HT3 antagonist dolasetron and its major metabolite MDL 73,405 on guinea-pig papillary muscle fibres and human heart sodium channels expressed in Xenopus oocytes. Dolasetron and MDL 73,405 (3-10 p M ) reduced the maximum depolarization rate
Comparison of the biological activities
โ
Guosu Wang; Richard Franklin; Ying Hong; Jorge D Erusalimsky
๐
Article
๐
2005
๐
Nature Publishing Group
๐
English
โ 217 KB
The pharmacokinetics and haemodynamics o
โ
R. D. Wynne; E. L. Crampton; I. D. Hind
๐
Article
๐
1985
๐
Springer
๐
English
โ 558 KB
Determination of pharmacokinetics of 8-c
โ
Xinyu Wang; Weiqing Zhang; Anqing Zou; Yaqing Lou
๐
Article
๐
2000
๐
Elsevier Science
โ 171 KB